News

Filter News By

Clear Filters

  1. CF Foundation Invests Up to $8.4M in SpliSense for the Development of Potential Rare Mutation Therapy

    May 13, 2021

    Today, the Cystic Fibrosis Foundation announced that it will invest up to $8.4 million in SpliSense’s Series B funding round to develop an antisense oligonucleotide therapy for people with cystic fibrosis who have splicing mutations and potentially other rare mutations.

  2. Molecular Analysis Identifies Key Differences in Lungs of People With Cystic Fibrosis

    May 6, 2021

    Researchers’ catalog of airway cell types could reveal targets for future genetic therapies

    Topics:

  3. CF Foundation Responds to NIH Call for Information on Diversity and Inclusion

    April 15, 2021

    The Cystic Fibrosis Foundation recently submitted comments to the National Institutes of Health on improving racial equity, diversity, and inclusion in the biomedical research workforce.

    Topics:

  4. William Skach, Chief Scientific Officer, to Retire From the CF Foundation

    March 31, 2021

    Dr. Skach will retire from the Cystic Fibrosis Foundation this summer.

    Topics:

  5. CF Foundation Awards Contract to Life Edit Therapeutics to Explore Gene Editing Technology in CF

    March 23, 2021

    Today, the Cystic Fibrosis Foundation announced that it has awarded up to $400,000 to Life Edit Therapeutics Inc. to explore the application of their unique gene editing technology in CF.

  6. CF Foundation Extends Collaboration With Exercise and Wellness Platform Beam Through 2021

    March 9, 2021

    The Cystic Fibrosis Foundation has renewed its commitment to supporting the health and well-being of adults living with cystic fibrosis by supporting free access to the online exercise, education, and well-being platform, Beam.

    Topics:

More Posts View All Posts

Related Content

Follow Us On